Research & Innovation

November 13, 2024 In a Canadian first, London Health Sciences Centre (LHSC) was the first and only hospital in Canada to implant a new extravascular implantable cardioverter defibrillator (ICD) during clinical trials. The global study has led to

November 4, 2024 Worldwide, more than 300 million non-cardiac surgeries are performed each year. Yet physicians remain unsure about the best way to manage blood pressure during operation to ensure patient safety and prevent damage to organs, like the

A team at London Health Sciences Centre Research Institute (LHSCRI) is the first in Canada to treat a patient with neuroendocrine tumours (NETs) – a rare form of cancer – using a radioisotope (an atom that releases radiation) called actinium-225

On October 16, 2024, hundreds of staff members, physicians, partners, community members and government officials joined us to celebrate the launch of London Health Sciences Centre Research Institute (LHSCRI). The day provided a behind-the-scenes look

A new London Health Sciences Centre Research Institute (LHSCRI) study published in PLOS Mental Health shows the long-term effectiveness of a personalized, flexible, and evidence-based treatment approach to mood and anxiety disorders in young adults

Go to LHSCRI.ca Every day at London Health Sciences Centre (LHSC), you’ll find curiosity and innovation thriving. As one team evaluates new cancer treatments, another is using artificial intelligence (AI) to diagnose rare diseases. Meanwhile

September 25, 2025 Two Lawson Health Research Institute scientists, Drs. Richard Kim and Emma Duerden, are part of a prestigious group selected by the Royal Society of Canada (RSC) to be fellows and new members of the RSC College for 2024. Dr. Kim

September 24, 2024 An international team of researchers involved in the Evaluation of the McGrath MAC (EMMA) trial, including those from Lawson Health Research Institute and London Health Sciences Centre (LHSC), have been awarded the prestigious John

September 19, 2024 Researchers from Lawson Health Research Institute, London Health Sciences Centre (LHSC) and Western University’s Schulich School of Medicine & Dentistry have explored the use of ChatGPT as a diagnostic tool for medical learners and